Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 95, Issue 8
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Multiple sclerosis
Original research
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
Online download statistics by month:
Online download statistics by month: March 2024 to September 2024
Abstract
Full
Pdf
Mar 2024
2847
315
132
Apr 2024
1385
89
61
May 2024
541
51
38
Jun 2024
336
23
19
Jul 2024
1296
88
52
Aug 2024
508
53
36
Sep 2024
412
24
15
Total
7325
643
353
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF